According to Precedence Research, the folate market size is forecasted to reach around US$ 1,481.05 million by 2030, growing at a 6% CAGR from 2021 to 2030.
Folate is vitamin B9 well-known for its role in supporting a healthy pregnancy along with the fetal development. As a main ingredient for anemia prevention, it is also commonly used in the pharmaceutical industry. Folate is used by women as a dietary supplement to prevent the creation of neural tube imperfections during pregnancy. It is a form of long-term supplementation that is also associated with minor reductions in the risk of cardiovascular disease and stroke. A major factor driving demand for the consumption of folate-based products and the internal growth of the target industry is increasing health consciousness among consumers worldwide. In addition, the main factor for the growth of the folate market is increase in female fertility rates, particularly in the Asia-Pacific region.
Download Free Sample Copy with TOC, Graphs & List of Figures @ https://www.precedenceresearch.com/sample/1236
Market Estimations Y-O-Y:
- Market Size Was Valued In 2021: US$ 876.52 Million
- Market Size Is Projected to Grow By 2022: US$ 928.27 Million
- Market Size Is Projected to Grow By 2023: US$ 983.30 Million
- Market Size Is Projected to Grow By 2024: US$ 1041.43 Million
- Market Size Is Projected to Grow By 2025: US$ 1104.09 Million
- Market Size Is Projected to Grow By 2026: US$ 1170.35 Million
- Market Size Is Projected to Grow By 2027: US$ 1240.88 Million
- Market Size Is Projected to Grow By 2028: US$ 1315.95 Million
- Market Size Is Projected to Grow By 2029: US$ 1395.90 Million
- Market Size Is Projected to Grow By 2030: US$ 1,481.05 Million
- Compound Annual Growth Rate (CAGR) from 2021 to 2030: 3 percent
Growth Factors:
Increased customer health awareness to improve immunity is a major factor driving the growth of the global demand for folate. Folate or vitamin B9 is required by the body to produce red blood cells. It is also involved in the normal growth & development of the organism, the processing of genetic materials like DNA and RNA, and many other functions of the body. The normal use of vitamin B9 tablets has been shown to be safe for consumption with no side effects on health. This substance is naturally present in a variety of plants, including dark green vegetable leaves. With the rising trend for a healthy lifestyle and balanced diet requirements, its demand is increasing. Folate deficiency in the human body results in many health problems. Macrocytic anemia, breath shortness, memory deficits, Weakness, complications of pregnancy is some of the other common health problems that occur from its deficiency. Consequently, all of the above variables promote the demand and growth of the target industry. In the forecast period 2021-2030, the emerging applications of folate may also have a positive effect on the development and revenue growth of the main operating industries. Another factor that generates enormous demand for folate and in turn drives growth of the target market is an increase in the fertility rate among women worldwide. Folate is used by women as a dietary supplement to prevent the creation of neural tube imperfections during pregnancy.
COVID-19 Impact:
The industrial report mentions the influence of the ongoing COVID-19 pandemic. The outbreak has caused disturbances in several industries and has hammered the logistics, resulting in delayed deliveries and cancellation of product demand. The folate report proficiently explains the resulting factors and concerns of manufacturers. Researchers have also well-explained how the producers and providers will tackle the ongoing epidemic and the key strategies to be adopted post-pandemic for turning their businesses back to normal.
Key Players:
The folate market is consolidated with a major number of manufacturers. The company profiling of key players in the market includes major business strategies, company overview and revenues. In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report. Primary research represents a bulk of research efforts, supplemented by extensive secondary research.
Report Highlights:
- On the basis of type, 5-MTHF calcium salt segment is expected hold largest revenue share and the 5-MTHF Glucosamine Salt segment is anticipated to register substantial CAGR during the forecast time-frame.
- On the basis of end-use, Pharmaceuticals & Nutraceuticals end use segment registered for the largest revenue with noteworthy share in 2020. In the nutraceuticals industry, this substance is used in the manufacture of supplemental vitamin capsules, powders, and cosmetics. The Food & beverages end-use is expected at substantial CAGR during the forecast time-frame.
- On the basis of form, global market is segregated as gummies, capsules, lozenges, powder, tablets, and others. Tablet segment will dominate the target market in the near future owing to its increasing demand worldwide. Powder form is expected register maximum CAGR during the forecast time-frame.
- Merck, Koninklijke DSM N.V, are foremost player in the global industry estimated for the remarkable share of the global folate market. The growth is accredited to various commercial strategies adopted by the enterprise.
Regional Analysis:
The report covers data for North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. In 2020, North America conquered the global market with a market share of more than 25%. The growth is owing to the increasing R&D activities, along with growing investment in the innovation of the product in the region. Increased manufacturing base in the area coupled with implementation of advanced technologies and expertise is expected to trigger the regional growth over the forecast years. Europe has seen a remarkable rise in folate materials. The presence of a strict restriction on the intake of additional nutraceuticals, along with a healthy diet, was responsible for this requirement. In addition, the European Union’s favorable legislation and reforms are expected to drive regional development over the forecast period. Asia Pacific anticipated growing at the maximum CAGR in the forecast period. Latin America and the African and Middle Eastern region will show perceptible growth over the forecast period owing to growing applications of folate in the countries including Brazil, Mexico, and GCC, of the regions.
Some of the prominent players in the folate market include:
- Medicamen Biotech Ltd.
- Koninklijke DSM N.V
- Superior Supplement Manufacturing
- Gnosis SPA
- Seidler Chemical Co, Inc.
- Nutritional Supplement Manufacturers, Inc.
- Shandong Xinfa Pharmaceutical Co.
- AIE Pharmaceuticals, Inc.
- Hebei Jiheng Group Pharmacy Co Ltd.
- Changzhou
- Niutang Chemical Plant Co. Ltd.
- Jiangxi Tianxin Pharmaceutical Co. Ltd.
- BASF SE
- HEMA PHARMACEUTICALS PVT. LTD.
- Merck
- Gemini Pharmaceuticals, Inc.
- Emcure Pharmaceuticals Ltd.
- Nantong Changhai Food Additive
Major Market Segments Covered:
By Type
5-MTHF Calcium Salt
5-MTHF Glucosamine Salt
By Form
Tablets
Capsules
Powder
Lozenges
Gummies
Others
By End-User
Food & Beverages
Pharmaceuticals & Nutraceuticals
Agriculture & Feed
Others
By Geography
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Malaysia
- Philippines
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC
- North Africa
- South Africa
- Rest of the Middle East & Africa
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions& Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Folate Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
Chapter 5. COVID 19 Impact on Folate Market
5.1. Covid-19: Folate Industry Impact
5.2. Folate Business Impact Assessment: Covid-19
5.2.1. Services Challenges/Disruption
5.2.2. Market Trends and Folate Opportunities in the COVID-19 Landscape for Major Markets
5.3. Strategic Measures against Covid-19
5.3.1. Government Support and Initiative to Combat Covid-19
5.3.2. Proposal for Folate Market Players to deal with Covid-19 Pandemic Scenario
Chapter 6. Folate Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.1.1. Increasing in fertility rate among women
6.1.1.2. Growing adoption of folic acid to treat kidney diseases
6.1.1.3. Increased health awareness among consumer
6.1.2. Market Restraints
6.1.2.1. Effect of high doses of folate
6.1.3. Market Opportunities
6.1.3.1. Advancements in the food service
Chapter 7. Global Folate Market: Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.1.1. Folate Market Revenue by Market Players (2017 – 2020)
7.1.1.2. Folate Market Revenue Market Share by Market Players (2017 – 2020)
7.1.2. Key Organic/Inorganic Strategies Adopted by Players
7.1.2.1. Product Portfolio Expansion, Geographic Expansion, Product Innovation
7.1.2.2. Merger and Acquisition, Collaboration and Partnerships
7.1.3. Market Players Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of End-users
Chapter 8. Global Folate Market, By Type
8.1. Folate Market, by Type, 2017-2030
8.1.1. 5-MTHF Calcium Salt
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. 5-MTHF Glucosamine Salt
8.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Folate Market, By End-use
9.1. Extrusion Sheet Market, by End-use, 2017-2030
9.1.1. Food & Beverages
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Pharmaceuticals & Nutraceuticals
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Agriculture & Feed
9.1.3.1. Market Revenue and Forecast (2017-2030)
9.1.4. Other End-Uses
9.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Folate Market, By Form
10.1. Extrusion Sheet Market, by Form, 2017-2030
10.1.1. Tablets
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Capsules
10.1.2.1. Market Revenue and Forecast (2017-2030)
10.1.3. Powder
10.1.3.1. Market Revenue and Forecast (2017-2030)
10.1.4. Lozenges
10.1.4.1. Market Revenue and Forecast (2017-2030)
10.1.5. Gummies
10.1.5.1. Market Revenue and Forecast (2017-2030)
10.1.6. Others
10.1.6.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Folate Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue Forecast by Grade(2017-2030)
11.1.2. Market Revenue Forecast by End-use (2017-2030)
11.1.3. Market Revenue Forecast by Form (2017-2030)
11.1.4. U.S
11.1.4.1. Market Revenue Forecast (2017-2030)
11.1.5. Canada
11.1.5.1. Market Revenue Forecast (2017-2030)
11.2. Europe
11.2.1. Market Revenue Forecast by Grade (2017-2030)
11.2.2. Market Revenue Forecast by End-use (2017-2030)
11.2.3. Market Revenue Forecast by Form (2017-2030)
11.2.4. UK
11.2.4.1. Market Revenue Forecast (2017-2030)
11.2.5. Germany
11.2.5.1. Market Revenue Forecast (2017-2030)
11.2.6. France
11.2.6.1. Market Revenue Forecast (2017-2030)
11.2.7. Rest of EU
11.2.7.1. Market Revenue Forecast (2017-2030)
11.3. Asia Pacific (APAC)
11.3.1. Market Revenue Forecast by Grade (2017-2030)
11.3.2. Market Revenue Forecast by End-use (2017-2030)
11.3.3. Market Revenue Forecast by Form (2017-2030)
11.3.4. China
11.3.4.1. Market Revenue Forecast (2017-2030)
11.3.5. India
11.3.5.1. Market Revenue Forecast (2017-2030)
11.3.6. Japan
11.3.6.1. Market Revenue Forecast (2017-2030)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue Forecast (2017-2030)
11.4. LATAM
11.4.1. Market Revenue Forecast by Grade (2017-2030)
11.4.2. Market Revenue Forecast by End-use (2017-2030)
11.4.3. Market Revenue Forecast by Form (2017-2030)
11.4.4. Brazil
11.4.4.1. Market Revenue Forecast (2017-2030)
11.4.5. Rest of LATAM
11.4.5.1. Market Revenue Forecast (2017-2030)
11.5. Middle East and Africa (MEA)
11.5.1. Market Revenue Forecast by Grade (2017-2030)
11.5.2. Market Revenue Forecast by End-use (2017-2030)
11.5.3. Market Revenue Forecast by Form (2017-2030)
11.5.4. GCC
11.5.4.1. Market Revenue Forecast (2017-2030)
11.5.5. North Africa
11.5.5.1. Market Revenue Forecast (2017-2030)
11.5.6. South Africa
11.5.6.1. Market Revenue Forecast (2017-2030)
11.5.7. Rest of MEA
11.5.7.1. Market Revenue Forecast (2017-2030)
Chapter 12. Company Profiles
12.1. Gnosis SPA
12.1.1. Company Overview, Business Information, Regional Presence
12.1.2. Product Portfolio Analysis
12.1.2.1. Product Details, Specification, Application
12.1.3. Revenue, Price, and Gross Margin (2017-2020)
12.1.4. Recent Developments and Strategies
12.2. Merck
12.2.1. Company Overview, Business Information, Regional Presence
12.2.2. Product Portfolio Analysis
12.2.2.1. Product Details, Specification, Application
12.2.3. Revenue, Price, and Gross Margin (2017-2020)
12.2.4. Recent Developments and Strategies
12.3. BASF SE
12.3.1. Company Overview, Business Information, Regional Presence
12.3.2. Product Portfolio Analysis
12.3.2.1. Product Details, Specification, Application
12.3.3. Revenue, Price, and Gross Margin (2017-2020)
12.3.4. Recent Developments and Strategies
12.4. Koninklijke DSM N.V
12.4.1. Company Overview, Business Information, Regional Presence
12.4.2. Product Portfolio Analysis
12.4.2.1. Product Details, Specification, Application
12.4.3. Revenue, Price, and Gross Margin (2017-2020)
12.4.4. Recent Developments and Strategies
12.5. Medicamen Biotech Ltd.
12.5.1. Company Overview, Business Information, Regional Presence
12.5.2. Product Portfolio Analysis
12.5.2.1. Product Details, Specification, Application
12.5.3. Revenue, Price, and Gross Margin (2017-2020)
12.5.4. Recent Developments and Strategies
12.6. Emcure Pharmaceuticals Ltd.
12.6.1. Company Overview, Business Information, Regional Presence
12.6.2. Product Portfolio Analysis
12.6.2.1. Product Details, Specification, Application
12.6.3. Revenue, Price, and Gross Margin (2017-2020)
12.6.4. Recent Developments and Strategies
12.7. Jiangxi Tianxin Pharmaceutical Co. Ltd.
12.7.1. Company Overview, Business Information, Regional Presence
12.7.2. Product Portfolio Analysis
12.7.2.1. Product Details, Specification, Application
12.7.3. Revenue, Price, and Gross Margin (2017-2020)
12.7.4. Recent Developments and Strategies
12.8. Seidler Chemical Co, Inc.
12.8.1. Company Overview, Business Information, Regional Presence
12.8.2. Product Portfolio Analysis
12.8.2.1. Product Details, Specification, Application
12.8.3. Revenue, Price, and Gross Margin (2017-2020)
12.8.4. Recent Developments and Strategies
12.9. Changzhou Niutang Chemical Plant Co. Ltd.
12.9.1. Company Overview, Business Information, Regional Presence
12.9.2. Product Portfolio Analysis
12.9.2.1. Product Details, Specification, Application
12.9.3. Revenue, Price, and Gross Margin (2017-2020)
12.9.4. Recent Developments and Strategies
12.10. Hebei Jiheng Group Pharmacy Co Ltd.
12.10.1. Company Overview, Business Information, Regional Presence
12.10.2. Product Portfolio Analysis
12.10.2.1. Product Details, Specification, Application
12.10.3. Revenue, Price, and Gross Margin (2017-2020)
12.10.4. Recent Developments and Strategies
12.11. Shandong Xinfa Pharmaceutical Co.
12.11.1. Company Overview, Business Information, Regional Presence
12.11.2. Product Portfolio Analysis
12.11.2.1. Product Details, Specification, Application
12.11.3. Revenue, Price, and Gross Margin (2017-2020)
12.11.4. Recent Developments and Strategies
12.12. Nantong Changhai Food Additive
12.12.1. Company Overview, Business Information, Regional Presence
12.12.2. Product Portfolio Analysis
12.12.2.1. Product Details, Specification, Application
12.12.3. Revenue, Price, and Gross Margin (2017-2020)
12.12.4. Recent Developments and Strategies
12.13. HEMA PHARMACEUTICALS PVT. LTD.
12.13.1. Company Overview, Business Information, Regional Presence
12.13.2. Product Portfolio Analysis
12.13.2.1. Product Details, Specification, Application
12.13.3. Revenue, Price, and Gross Margin (2017-2020)
12.13.4. Recent Developments and Strategies
12.14. Superior Supplement Manufacturing
12.14.1. Company Overview, Business Information, Regional Presence
12.14.2. Product Portfolio Analysis
12.14.2.1. Product Details, Specification, Application
12.14.3. Revenue, Price, and Gross Margin (2017-2020)
12.14.4. Recent Developments and Strategies
12.15. Gemini Pharmaceuticals, Inc.
12.15.1. Company Overview, Business Information, Regional Presence
12.15.2. Product Portfolio Analysis
12.15.2.1. Product Details, Specification, Application
12.15.3. Revenue, Price, and Gross Margin (2017-2020)
12.15.4. Recent Developments and Strategies
12.16. Nutritional Supplement Manufacturers, Inc.
12.16.1. Company Overview, Business Information, Regional Presence
12.16.2. Product Portfolio Analysis
12.16.2.1. Product Details, Specification, Application
12.16.3. Revenue, Price, and Gross Margin (2017-2020)
12.16.4. Recent Developments and Strategies
12.17. AIE Pharmaceuticals, Inc.
12.17.1. Company Overview, Business Information, Regional Presence
12.17.2. Product Portfolio Analysis
12.17.2.1. Product Details, Specification, Application
12.17.3. Revenue, Price, and Gross Margin (2017-2020)
12.17.4. Recent Developments and Strategies
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms
Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.
Purchase Full Research Report (Single User License US$ 4500) @ https://www.precedenceresearch.com/checkout/1236
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com